Hotakainen K - Search Results

1

The role of SPINK1 in ETS rearrangement-negative prostate cancers.

Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, Demichelis F, Helgeson BE, Laxman B, Morris DS, Cao Q, Cao X, Andrén O, Fall K, Johnson L, Wei JT, Shah RB, Al-Ahmadie H, Eastham JA, Eggener SE, Fine SW, Hotakainen K, Stenman UH, Tsodikov A, Gerald WL, Lilja H, Reuter VE, Kantoff PW, Scardino PT, Rubin MA, Bjartell AS, Chinnaiyan AM. Tomlins SA, et al. Among authors: hotakainen k. Cancer Cell. 2008 Jun;13(6):519-28. doi: 10.1016/j.ccr.2008.04.016. Cancer Cell. 2008. PMID: 18538735 Free PMC article.

2

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Gaber A, Nodin B, Hotakainen K, Nilsson E, Stenman UH, Bjartell A, Birgisson H, Jirström K. Gaber A, et al. Among authors: hotakainen k. BMC Cancer. 2010 Sep 17;10:498. doi: 10.1186/1471-2407-10-498. BMC Cancer. 2010. PMID: 20849596 Free PMC article.

3

Will emerging prostate cancer markers redeem themselves?

Hotakainen K, Stenman UH. Hotakainen K, et al. Clin Chem. 2010 Aug;56(8):1212-3. doi: 10.1373/clinchem.2010.147223. Epub 2010 Jun 22. Clin Chem. 2010. PMID: 20570933 No abstract available.

4

Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.

Gaber A, Stene C, Hotakainen K, Nodin B, Palmquist I, Bjartell A, Stenman UH, Jeppsson B, Johnson LB, Jirström K. Gaber A, et al. Among authors: hotakainen k. Radiat Oncol. 2011 Aug 24;6:100. doi: 10.1186/1748-717X-6-100. Radiat Oncol. 2011. PMID: 21864386 Free PMC article.

5

Monitoring of seminoma patients with serum markers.

Hotakainen K, Lempiäinen A, Stenman UH. Hotakainen K, et al. Cancer. 2013 Jul 1;119(13):2511. doi: 10.1002/cncr.28008. Epub 2013 Apr 12. Cancer. 2013. PMID: 23584987 Free article. No abstract available.

6

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.

Gaber A, Johansson M, Stenman UH, Hotakainen K, Pontén F, Glimelius B, Bjartell A, Jirström K, Birgisson H. Gaber A, et al. Among authors: hotakainen k. Br J Cancer. 2009 May 19;100(10):1540-8. doi: 10.1038/sj.bjc.6605047. Epub 2009 Apr 21. Br J Cancer. 2009. PMID: 19384300 Free PMC article.

7

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, Stenman UH, Bjartell A. Paju A, et al. Among authors: hotakainen k. Eur Urol. 2007 Dec;52(6):1670-9. doi: 10.1016/j.eururo.2007.01.096. Epub 2007 Feb 5. Eur Urol. 2007. PMID: 17306443

8

Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.

Hotakainen K, Ljungberg B, Haglund C, Nordling S, Paju A, Stenman UH. Hotakainen K, et al. Int J Cancer. 2003 May 1;104(5):631-5. doi: 10.1002/ijc.11000. Int J Cancer. 2003. PMID: 12594819

9

Human chorionic gonadotropin in cancer.

Stenman UH, Alfthan H, Hotakainen K. Stenman UH, et al. Among authors: hotakainen k. Clin Biochem. 2004 Jul;37(7):549-61. doi: 10.1016/j.clinbiochem.2004.05.008. Clin Biochem. 2004. PMID: 15234236 Review.

10

Expression of human chorionic gonadotropin in testicular germ cell tumors.

Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH. Lempiäinen A, et al. Among authors: hotakainen k. Urol Oncol. 2014 Jul;32(5):727-34. doi: 10.1016/j.urolonc.2013.11.007. Epub 2014 Feb 4. Urol Oncol. 2014. PMID: 24502963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters